1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, 97.0%, 1g

(5aR,10bS)-2-(Perfluorophenyl)-4,5a,6,10b-tetrahydro-2H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-11-ium tetrafluoroborate, 98%, 1g

5,6,7,8-Tetrahydro-naphthalene-2-carbaldehyde, 95.0%, 250mg

2,4-Dichloro-5-(difluoromethyl)pyridine, 98%, 500mg

9-Methyl-6-trifluoromethyl-9H-purin-2-ylamine, 95.0%, 1g

2-Amino-4,5,6,7-tetrahydro-benzo[ b ]thiophene-3-carboxylic acid amide, 96.0%, 1g

2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide, 98.0%, 5g

4,4'-Diamyloxybiphenyl>98.0%(GC)5g

2-Chloro-6-nitrotoluene>99.0%(GC)25g

(2S,3S,4S,5R,6S)-6-[(4,6-dihydroxy-5-oxo-2-phenyl-5H-chromen-7-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid, 95%, 5g

anti-Cyclin-Dependent Kinase 4 mouse monoclonal, DCS-156, 1 ml

3-[(3-bromophenyl)amino]propanoic acid, 98%, 250mg

4-Hydroxypyridine, 99.0%, 500g